Previous Close | 45.00 |
Open | 38.00 |
Bid | 41.70 |
Ask | 44.80 |
Strike | 175.00 |
Expire Date | 2024-07-19 |
Day's Range | 38.00 - 45.00 |
Contract Range | N/A |
Volume | |
Open Interest | 32 |
Hologic's (HOLX) GYN Surgical Q2 performance was driven by strong results from MyoSure and Fluent Fluid Management.
Lantheus' (LNTH) robust revenues from the majority of its segments drive its first-quarter performance.
Bruker's (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024.